跳至主要内容
临床试验/IRCT20200504047295N1
IRCT20200504047295N1已完成3 期

Evaluation effectiveness of Shallomin syrup compared with current treatment protocol on the elimination of clinical symptoms and duration of hospitalization in admitted patients with COVID-19: A double-blind, parallel-group, multicenter, and randomized controlled trial

Ahvaz University of Medical Sciences0 个研究点目标入组 90 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
已完成
入组人数
90

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 75 years(—)
性别
All

入选标准

  • COVID-19 patients who have clinical signs of COVID-19 infection such as fever, cough, sputum production, sore throat.
  • Patients with the positive CT scan
  • Patients with the positive RT-qPCR for corona virus 2019
  • Patients who declare informed consent for enrollment in this study.

排除标准

  • Pregnant women (based on WHO protocol)
  • Lactating women (based on WHO protocol)
  • Individuals who exhibit specific allergic reactions to shallomin syrup.
  • Patients with heart failure, kidney failure, hepatitis, hemophilia, thalassemia or leukemia

研究者

相似试验